Evidence map›Paper›PMID 16041617›Full record

Trial reportEuropean journal of nuclear medicine and molecular imaging2006

Reduced 123I-BMIPP uptake implies decreased myocardial flow reserve in patients with chronic stable angina.

Hiroyuki Kageyama, Koichi Morita, Chietsugu Katoh, Takahiro Tsukamoto, Kazuyuki Noriyasu, Megumi Mabuchi, Masanao Naya, Yuko Kawai, Nagara Tamaki

Abstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in European journal of nuclear medicine and molecular imaging, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Imaging of myocardial fatty acid oxidation.Biochimica et biophysica acta · 2016
    Review
  2. Review
  3. Metabolic imaging using SPECT.European journal of nuclear medicine and molecular imaging · 2007
    Review
  4. Diagnostic and prognostic value of BMIPP imaging.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2007
    Review
  5. Nuclear cardiology in the literature.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2006
    Article
  6. Myocardial ischaemia and metabolic memory.European journal of nuclear medicine and molecular imaging · 2006
    Article
  7. The Japanese experience with metabolic imaging in the clinical setting.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Hiroyuki KageyamaDepartment of Nuclear Medicine, Hokkaido University Graduate School of Medicine, Kita-15, Nishi-7, Kita-ku, Sapporo 060-8638, Japan.
Koichi Morita
Chietsugu Katoh
Takahiro Tsukamoto
Kazuyuki Noriyasu
Megumi Mabuchi
Masanao Naya
Yuko Kawai
Nagara Tamaki
Hokkaido University · JPHokko Memorial Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeLong-chain fatty acid (LCFA) is the main energy source for normal myocardium at rest, but in ischemic myocardium, the main energy substrate shifts from LCFA to glucose. 123I-BMIPP is a radiolabeled LCFA analog. In chronic stable angina without previous infarction, we suppose that reduced 123I-BMIPP uptake is related to the substrate shift in myocardium with decreased myocardial flow reserve (MFR). The purpose of this study was to relate 123I-BMIPP uptake to rest myocardial blood flow (MBF), hyperemic MBF, and MFR assessed with 15O-water positron emission tomography (PET).

methodsWe enrolled 21 patients with chronic stable angina without previous infarction, all of whom underwent 123I-BMIPP single-photon emission computed tomography (SPECT) and 15O-water PET. The left ventricle was divided into 13 segments. In each segment, rest MBF and hyperemic MBF were measured by PET. 123I-BMIPP uptake was evaluated as follows: score 0=normal, 1=slightly decreased uptake, 2=moderately decreased uptake, 3=severely decreased uptake, and 4=complete defect. 123I-BMIPP uptake was compared with rest MBF, hyperemic MBF, and MFR.

resultsThe numbers of segments with 123I-BMIPP scores 0, 1, 2, 3, and 4 were 178, 40, 25, 24, and 0, respectively. The rest MBFs for scores 0, 1, 2, and 3 were 0.93+/-0.25, 0.86+/-0.21, 0.97+/-0.30, and 0.99+/-0.37 ml/min/g, respectively. The hyperemic MBFs for scores 0, 1, 2, and 3 were 2.76+/-1.29, 1.84+/-0.74, 1.37+/-0.39, and 1.08+/-0.40 ml/min/g, respectively. The MFRs for scores 0, 1, 2, and 3 were 3.01+/-1.38, 2.20+/-0.95, 1.44+/-0.22, and 1.10+/-0.26, respectively. As 123I-BMIPP uptake declined, hyperemic MBF and MFR decreased.

conclusionIn chronic stable angina without previous infarction, reduced 123I-BMIPP uptake implies decreased MFR.

Indexed as

AdultAgedAngina, UnstableCoronary Artery DiseaseCoronary CirculationFatty AcidsFemaleHumansIodobenzenesMaleMiddle AgedOxygen RadioisotopesRadionuclide ImagingRadiopharmaceuticalsRisk AssessmentRisk FactorsFatty AcidsIodobenzenesiodofiltic acidOxygen RadioisotopesRadiopharmaceuticals

Identifiers

PMID16041617
OpenAlexW2015599284

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.